Maxigen Biotech Inc
TWSE:1783

Watchlist Manager
Maxigen Biotech Inc Logo
Maxigen Biotech Inc
TWSE:1783
Watchlist
Price: 41.9 TWD 0.12%
Market Cap: 3.7B TWD
Have any thoughts about
Maxigen Biotech Inc?
Write Note

Wall Street
Price Targets

Price Targets Summary
Maxigen Biotech Inc

There are no price targets for Maxigen Biotech Inc.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Maxigen Biotech Inc Competitors:
Price Targets
KAREX
Karex Bhd
29% Upside
4911
Shiseido Co Ltd
56% Upside
003006
Chongqing Baiya Sanitory Products Co Ltd
15% Upside
ELF
elf Beauty Inc
48% Upside
ULVR
Unilever PLC
13% Upside
ITP
Interparfums SA
33% Upside
BEI
Beiersdorf AG
18% Upside
SAR
Gr Sarantis SA
30% Upside

Revenue
Forecast

Revenue Estimate
Maxigen Biotech Inc

For the last 8 years the compound annual growth rate for Maxigen Biotech Inc's revenue is 11%. The projected CAGR for the next 5 years is -6%.

11%
Past Growth
-6%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Maxigen Biotech Inc

The compound annual growth rate of Maxigen Biotech Inc's operating income for the next 5 years is -16%.

N/A
Past Growth
-16%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Maxigen Biotech Inc

The compound annual growth rate of Maxigen Biotech Inc's net income for the next 5 years is -14%.

N/A
Past Growth
-14%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Maxigen Biotech Inc's stock price target?
Not Available

Maxigen Biotech Inc doesn't have any price targets made by Wall Street professionals.

What is Maxigen Biotech Inc's Revenue forecast?
Projected CAGR
-6%

For the last 8 years the compound annual growth rate for Maxigen Biotech Inc's revenue is 11%. The projected CAGR for the next 5 years is -6%.

What is Maxigen Biotech Inc's Operating Income forecast?
Projected CAGR
-16%

The compound annual growth rate of Maxigen Biotech Inc's operating income for the next 5 years is -16%.

What is Maxigen Biotech Inc's Net Income forecast?
Projected CAGR
-14%

The compound annual growth rate of Maxigen Biotech Inc's net income for the next 5 years is -14%.

Back to Top